Atlas Trials

16-week Flexible vs. 8-week Semaglutide Titration

Clinical trial NCT04447859 · UNKNOWN

Trial details

NCT number
NCT04447859
Sponsor
Tel-Aviv Sourasky Medical Center
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes type2
Start date
2020-02-23
Primary completion
2022-05-10
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.